Rocket Lab's 95th Launch Is Real — the 78% Rally Is a Price Target

On Friday an Electron rocket lifted off from Rocket Lab's launch pad in New Zealand carrying a single Earth-observation satellite into a 500-kilometre orbit. It was the company's 16th launch of 2026 and its 95th Electron mission overall — a cadence the firm has been stacking roughly every couple of weeks. The stock ticked up about 2% in premarket trading.

A headline you may have seen on the way in frames this as analysts projecting a 78% rally. That sentence deserves a closer read before it does any work, because it converts a static number into a prediction. The 78% is not a forecast of what the stock will return. It is what the average twelve-month price target among the roughly two dozen analysts covering Rocket Lab looks like when measured from the current price. The consensus target sits around $107 to $110, and the stock is trading near $63 — a level it reached only after falling about 58% from its 52-week high near $151. The headline is a measurement from a lower base, not a promise.

So the question worth asking is not whether the 95th launch happened — it did, and it was clean. The question is what the market is actually paying for, and whether that launch gets you any closer to it.

Execution is real; that is not the hard part

Set aside the launch for a moment and look at the scoreboard, because the company is, on its own operating terms, an execution machine. Second-quarter revenue hit a record $234 million, up 62% year over year. Backlog reached a record $2.36 billion, up 137%. Management guided third-quarter revenue to another record range of $250 million to $265 million. The satellite-manufacturing and launch sides are both growing, and the company signs new contracts faster than it books the old ones.

None of that is in dispute, and none of it is cheap. Rocket Lab is not profitable — it lost $49 million in the second quarter and roughly $94 million across the first half of the year. And even after a drawdown that cut the stock nearly in half, it traded at roughly 59 times trailing-twelve-month revenue in August, a multiple that was built when the share price was higher and that has only compressed modestly since. You are paying a forward-looking price for a story, not a multiple on today's earnings, because on today's earnings there are none.

What the multiple is really buying

That story has two parts, and here is the uncomfortable part: the launch that just happened confirms neither of them.

The first is Neutron, Rocket Lab's medium-lift reusable rocket. It has never flown. Management has guided to delivering the vehicle to the pad in the fourth quarter of 2026, and has already begun to warn that the window for a first flight "this year" is narrowing — the debut may slip into 2027. Yet a meaningful slice of the backlog depends on it, including a $397 million Space Force contract to deliver spacecraft on Neutron. The small-ride Electrons that keep launching are the dependable cash machine; they are not the thing the valuation is built on.

The second is the biggest bet: a planned $8 billion acquisition of satellite operator Iridium, announced in June and expected to close around mid-2027. It is financed half in cash — through a $3.6 billion bridge loan — and half in new Rocket Lab stock, so it adds both debt and share count when it lands. In exchange it folds in an operating network serving about 2.55 million subscribers.

Seen from the right altitude, that combination is genuinely the exponential-age shape: own the rocket and own the constellation, launch your own satellites with your own rocket, feed the network, and compound the advantage over time. It is the SpaceX template applied with a smaller balance sheet — a self-launching, vertically integrated player with recurring subscription revenue instead of a one-ticket-at-a-time launch business. The mechanism is real, and it is the reason the multiple exists at all.

The discipline nobody prints in the headline

Here is where the cyclical discipline has to stand next to the secular optimism. An exponential curve still needs its catalyst to actually fire. The launch cadence proves the fee-for-launch model works and that the company does what it says — that is genuinely reassuring, and it is why Rocket Lab is not a fabrication. But cadence does not by itself validate a valuation that was written when the story was "Neutron flies and Iridium closes." Both of those catalysts have been sliding toward the future, and the market has already repriced once in response: the stock sits about 58% below its high, with momentum measures weakening. That is what a narrative looks like after the consensus it pulled in starts to doubt its own timeline.

The asymmetry is worth sitting with. The operating machine is doing precisely what it said it would — the launch is proof of that. The valuation is doing what markets always do when a story is dominant: assuming near-perfection on the two things that have not yet been proven. A clean launch tells you the company is real. It does not tell you the 78% is coming, because the 78% was never a trajectory — it is a target that a halved stock makes look large.

Keep the two separate. The 95th mission is a fact you could hold and verify. The rally is a hope that still-unflown hardware and a debt-funded merger deliver on time. That distinction is the trade.